APLLTD - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.1

💊 APLLTD shows strong volume, technical support, and earnings momentum — a favorable setup for intraday trading with mild caution on MACD.

📈 Positive

• 🔹 RSI at 62.3: Bullish zone, indicating strong buying interest without being overbought.
• 🔹 Price Above 50 & 200 DMA: Current price (₹961) is above both DMAs (₹934 & ₹953), confirming trend strength.
• 🔹 Volume Surge: Current volume (16.6L) is significantly higher than 1-week average (4.86L), showing strong intraday participation.
• 🔹 Quarterly PAT Growth: Up from ₹104 Cr to ₹179 Cr, a 15.6% improvement.
• 🔹 Low Debt: Debt-to-equity ratio of 0.23 reflects financial stability.

⚠️ Limitation

• 🔸 MACD at -3.20: Bearish crossover suggests short-term momentum weakness.
• 🔸 PEG Ratio at -12.9: Indicates valuation concerns relative to growth.
• 🔸 DII Outflow: Domestic institutional holdings declined by 0.16%.
• 🔸 ROCE & ROE: Moderate efficiency at 11.3% and 9.68% respectively.

🚫 Company Negative News

• 📉 Valuation Pressure: Analysts cautious on high P/E (42.5) vs industry average (33.1), despite earnings growth.

✅ Company Positive News

• 💊 Product Expansion: New launches in specialty APIs and generics driving revenue growth.
• 📈 EPS of ₹22.6: Reflects solid earnings base.

🏦 Industry

• 🧪 Sector: Pharmaceuticals — APIs, Generics, Specialty Formulations.
• 📊 Industry PE: 33.1, slightly below APLLTD’s PE of 42.5, suggesting moderate premium.

📌 Conclusion

• 📉 Intraday Setup: Strong volume and RSI favor upside; ideal for momentum-based trades with MACD caution.
• 💰 Optimal Buy Price: ₹955–₹960 (near 200 DMA support).
• 📈 Profit Exit Level: ₹975–₹985 (short-term resistance zone).
• 🛑 Stop Loss: ₹945 (below 50 DMA).
• ⏳ If Holding: Exit if RSI crosses 65 or price fails to hold above ₹960 intraday.

I can also compare APLLTD’s intraday setup with other pharma mid-caps showing similar volume and RSI strength.